U.S., Sept. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07179978) titled 'Lorazepam and the Risk of Serious Adverse Events' on Sept. 05. Brief Summary: This is a p... Read More
U.S., Sept. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07181577) titled 'Sleep and Blankets' on Sept. 12. Brief Summary: Purpose The primary aim of this research... Read More
U.S., Sept. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07181161) titled 'Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostat... Read More
U.S., Sept. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07180589) titled 'Advancing Assessment for Disorders of Consciousness' on Aug. 25. Brief Summary: Over the ... Read More
U.S., Sept. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07179536) titled 'Time to Ambulation After ProGlide Closure' on Sept. 16. Brief Summary: Transradial access... Read More
U.S., Sept. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07181187) titled 'Phase II Clinical Trial of MH004 Ointment in Patients With Non-segmental Vitiligo' on Sept... Read More
U.S., Sept. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07179692) titled 'CEA-Targeted CAR-T Therapy in CEA-Positive Advanced Solid Tumors' on Sept. 11. Brief Summ... Read More
U.S., Sept. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07181265) titled 'Drug-Drug Interaction of JMKX003142 With Amiodarone and Febuxostat in Healthy Subjects' on... Read More
U.S., Sept. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07179952) titled 'Efficacy and Safety of Slow Release DHEA' on Aug. 06. Brief Summary: There is evidence to... Read More
U.S., Sept. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07181837) titled 'A Phase 1/2 Study of the Safety and Efficacy of MVX-220 in Angelman Syndrome' on Sept. 06.... Read More